Earlier this month, Carl Icahn declared that Bill Ackman of Pershing Square is “dead wrong” on his short bet relating to Herbalife. He was correct, and Ackman knows it. In a last-ditch effort to make his bet pay off, Ackman has started a deceptive public relations war to kill the nutrition company. Show More Summary
Household hedge fund names such as Bill Ackman's Pershing Square ’s Bill Ackman, Daniel Loeb’s Third Point Capital and David Einhorn’s Greenlight Capital are nowhere to be found in the Barron's 2016 List of Best 100 hedge funds. Instead,...Show More Summary
Activist hedge fund investor Bill Ackman is bringing his Herbalife battle to the Hamptons this summer. The documentary film Betting on Zero, directed by Ted Braun, examines Ackman's crusade to... To view the full story, click the title link.
I love the markets. They are making a mockery of ‘smart’ people this year. Smart people breaking what seem to be basic and well treaded rules. Bill Ackman implodes on a debt loaded rollup called Valeant…what a putz and not the first. Theranos used magic speak to get Walgreens to roll out a fake blood …
Things were obviously getting a little too boring around Wall Street for Carl Icahn. The billionaire investor and founder of Icahn Enterprises decided to dredge up one of his old feuds on Thursday. He told CNBC that Pershing Square's...Show More Summary
In an unexpected development, in his latest note the best market inflection point indicator alive, Dennis Gartman, has decided to pick on none other than billionaire Bill Ackman. This is the result: We wish to talk once again about the...Show More Summary
Valeant Pharmaceuticals International (VRX) is the dumpster fire that hedge fund manager Bill Ackman can’t seem to put out. Valeant plunged 13% in heavy trading on Tuesday after the company slashed its yearly earnings outlook. Ackman’s Pershing Square Capital Management is among Valeant’s largest shareholders. Show More Summary
On Tuesday, respected value fund Ruane, Cunniff & Goldfarb disclosed in a securities filing it sold over 14 million Valeant shares, paring its stake in the company by almost 50%.
Acks has yet to get his groove back.
We hope Bill Ackman is meditating today.
Bill Ackman/Allergan are grateful.
Legendary investor Carl Icahn has announced a new position in Allergan Pharmaceuticals. Allergan has been very popular on Wall Street. Back in 2014, billionaire hedge fund manager Bill Ackman tried to team up with Valeant Pharmaceuticals to buy Allergan in a hostile takeover. Show More Summary
A non-actor, to boot. That's how deep his connections run.
The market may be surging again, but that will hardly comfort Bill Ackman who later today is expected to report later today that his hedge fund remains roughly 20% YTD, or perhaps even worse following news from the NY Post, that hisShow More Summary
WASHINGTON -- Billionaire activist investors are joining forces to raid Congress for more power. According to a Wall Street Journal report, hedge fund operators Paul Singer, Carl Icahn, Bill Ackman, Barry Rosenstein and Dan Loeb formed a lobbying trade group called the Council for Investor Rights and Corporate Accountability, or CIRCA. Show More Summary
Pershing Square just posted a first-quarter letter to shareholders running through the hedge fund's investments. The fund, and its founder Bill Ackman, had a torrid start to the year. It seemed almost all of the fund's investment went...Show More Summary